Search Results 1021-1030 of 18365 for Hepatitis b

  1. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...

  2. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Have active hepatitis B or hepatitis C defined as: HBV: hepatitis B surface ... hepatitis B core antibody (HBc Ab) positive subjects;; HCV: HCV ...

  3. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    In this study, we will examine the potential side effects experienced after receiving the new hepatitis B vaccine (Heplisav-B) in patients with ulcerative ...

  4. Publications - Jeffrey B. Peel, M.D. - Mayo Clinic

    Tsikvadze M, Machado B, Rose M, Peacock S, Peel JB, Ng L, Kramer C, Freeman WD. Diffuse cerebral edema with uncal herniation leading to brain death in patient ...

  5. Joint pain When to see a doctor - Mayo Clinic

    Drinking after hepatitis C cure: Is it safe? Early HIV symptoms: What are they? ... Heart cancer: Is there such a thing? ... Hepatitis B and Hepatitis C: What's the ...

  6. A Study to Evaluate Immunotherapy for Non-Small Cell Lung Cancer - Mayo Clinic

    as Hepatitis B surface antigen [HBsAg] reactive) or known active Hepatitis C virus (defined as HCV Ribonucleic acid (RNA) [qualitative] is detected) ...

  7. A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis - Mayo Clinic

    Hepatitis B or Hepatitis C. - Impaired cardiac function or clinically significant cardiac diseases - Patients with Child-Pugh Class B or C - Impairment of ...

  8. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

    Subjects with evidence of hepatitis B or C virus infection, unless their hepatitis is considered to have been cured. (Note that subjects with prior hepatitis B ...

  9. MDM2 Inhibitor AMG-232 and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma - Mayo Clinic

    Patients with known Positive Hepatitis B Surface Antigen (HepBsAg) (indicative of chronic Hepatitis B), positive Hepatitis total core antibody with negative ...

  10. A Study to Provide Access to CTL019 Out of Specification Managed Access Program (MAP) for ALL or DLBCL Patients - Mayo Clinic

    ... b-cell lymphoma (DLBCL) patients with out of specification ... Patients with active replication of Hep B or active or latent Hep C. History ...